“bristol-myers-squibb” Archives

in
Entry Author Date Location
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M 07/06/16 Boston
Bristol-Myers Squibb Boosts Cancer Drug Pipeline with Cormorant Deal 07/05/16 New York
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
Struggling Aegerion, QLT to Merge, Change Name to Novelion 06/15/16 Boston
Alpine Immune Sciences, Former Dendreon CEO’s Latest Startup, Gets $48M 06/13/16 Seattle
Bind Therapeutics Sheds Employees, Considers New Capital or Deals 04/06/16 Boston
East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More 04/01/16 Boston
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Startups Begin to Emerge From NYU’s “Virtual” Biotech Factory 03/17/16 New York
Ensemble Quietly Amasses Cancer Drug Pipeline, Scouts for New Deals 03/08/16 Boston
TRImaran Licenses WSU Compounds to Develop Neuro Drugs 02/11/16 Detroit Ann Arbor
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Heat Biologics Seeks More Cash for Bladder Cancer Immunotherapy Push 01/22/16 Raleigh Durham
West Coast Biotech Roundup: StemCells, Five Prime, Qualcomm & More 01/22/16 San Francisco
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials 01/04/16 Boston
With Startup, Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again 12/10/15 New York
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal 11/02/15 Raleigh Durham
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
Five Prime, Bristol Shake Hands Again in New $350M Cancer Pact 10/15/15 San Francisco
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug 08/31/15 Boston
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Page 1 of 12 next page »